Integer (NYSE:ITGR) PT Raised to $144.00 at KeyCorp

Integer (NYSE:ITGR) had its price target upped by KeyCorp from $139.00 to $144.00 in a research report report published on Tuesday morning, Benzinga reports. They currently have an overweight rating on the medical equipment provider’s stock.

Other equities research analysts have also recently issued research reports about the company. Truist Financial boosted their price target on Integer from $145.00 to $150.00 and gave the company a buy rating in a research note on Monday. Bank of America increased their price target on shares of Integer from $135.00 to $145.00 and gave the stock a buy rating in a research note on Tuesday, October 1st. Benchmark reaffirmed a buy rating and issued a $130.00 price objective on shares of Integer in a research note on Wednesday, October 2nd. Citigroup increased their target price on shares of Integer from $124.00 to $130.00 and gave the stock a neutral rating in a research report on Tuesday, October 1st. Finally, Oppenheimer initiated coverage on Integer in a research report on Tuesday, July 16th. They issued an outperform rating and a $135.00 price target for the company. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Integer has an average rating of Moderate Buy and an average price target of $138.71.

Integer Stock Down 0.7 %

Integer stock opened at $131.46 on Tuesday. Integer has a twelve month low of $69.40 and a twelve month high of $133.52. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.96 and a current ratio of 3.29. The firm has a market cap of $4.40 billion, a PE ratio of 45.49, a P/E/G ratio of 1.86 and a beta of 1.08. The firm’s 50 day moving average price is $125.84 and its two-hundred day moving average price is $120.34.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.06. Integer had a return on equity of 11.48% and a net margin of 6.31%. The business had revenue of $436.20 million during the quarter, compared to analyst estimates of $437.00 million. During the same period last year, the company earned $1.14 earnings per share. Integer’s quarterly revenue was up 9.0% compared to the same quarter last year. On average, research analysts predict that Integer will post 5.3 EPS for the current fiscal year.

Insider Transactions at Integer

In other news, Director Jean M. Hobby sold 11,960 shares of the firm’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total value of $1,431,133.60. Following the sale, the director now owns 2,280 shares in the company, valued at approximately $272,824.80. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Integer

Institutional investors have recently added to or reduced their stakes in the company. Driehaus Capital Management LLC raised its holdings in Integer by 62.5% in the 2nd quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock valued at $40,880,000 after acquiring an additional 135,750 shares in the last quarter. F M Investments LLC acquired a new position in shares of Integer in the second quarter valued at $11,143,000. Point72 Europe London LLP acquired a new stake in Integer during the second quarter worth $6,241,000. Earnest Partners LLC increased its holdings in Integer by 3.2% in the 2nd quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock valued at $139,911,000 after buying an additional 37,340 shares during the period. Finally, Congress Asset Management Co. MA raised its stake in shares of Integer by 7.5% in the 1st quarter. Congress Asset Management Co. MA now owns 453,260 shares of the medical equipment provider’s stock valued at $52,886,000 after buying an additional 31,736 shares in the last quarter. 99.29% of the stock is owned by institutional investors and hedge funds.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.